New Recombinant Ad5 Vector Overcomes Ad5 Immunity Allowing for Multiple Safe, Homologous Immunizations

Elizabeth S. Gabitzsch^* and Frank R. Jones

Etubics Corporation, Seattle, WA 98119, USA

^*Corresponding Author: Elizabeth S. Gabitzsch, Etubics Corporation, 410 West Harrison Street, Suite 100, Seattle, WA 98199, USA, Tel: (206) 838-5110, Fax: (206) 838-2978 Email: